Among the treatments for type 2 DM, metformin reportedly has a protective effect against TB incidence [22], whereas dipeptidyl peptidase-4 (DPP-4) inhibitors have a neutral role in mycobacterial pulmonary infection [23]. This evidence concerns the gene DPP4 and Mycobacterium infection.